Dean Johnston

Hunter College — United States

Immunology and Microbiology · Life Sciences

19h-index1.4kcitations38works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(13), vaccines and immunoinformatics approaches(9), Cholesterol and Lipid Metabolism(6), RNA Interference and Gene Delivery(5), T-cell and B-cell Immunology(4)

Publications38 total

Multiple Breast Cancer Cell-Lines Derived from a Single Tumor Differ in Their Molecular Characteristics and Tumorigenic Potential
PLoS ONE·2013· 19 citedOpen Access
Enhanced Immunogenicity of<i>Plasmodium falciparum</i>Peptide Vaccines Using a Topical Adjuvant Containing a Potent Synthetic Toll-Like Receptor 7 Agonist, Imiquimod
Infection and Immunity·2008· 56 citedOpen Access
TLR7 imidazoquinoline ligand 3M-019 is a potent adjuvant for pure protein prototype vaccines
Cancer Immunology Immunotherapy·2006· 42 citedOpen Access
Topical imiquimod is a potent adjuvant to a weakly-immunogenic protein prototype vaccine
Vaccine·2005· 61 cited
Interleukin-2/liposomes potentiate immune responses to a soluble protein cancer vaccine in mice
Cancer Immunology Immunotherapy·2005· 19 citedOpen Access
Extended survival and broad immune responses following vaccination of patients with metastatic melanoma with peptide-pulsed CD34+ progenitor derived dendritic cells (DCs)
Journal of Clinical Oncology·2005· 1 cited
360 INCREASED FREQUENCY OF HLA-B44, -B8, -DR17(3) -DQ2, AND -DR7 -DQ2 IN PATIENTS WITH NORMAL SERUM IMMUNOGLOBULINS WHO SUFFER WITH RECURRENT SINOPULMONARY INFECTIONS
Journal of Investigative Medicine·2005
Heterogeneous antibody response to polyvalent melanoma vaccines in syngeneic mice
Cancer Immunology Immunotherapy·2004· 9 citedOpen Access
Vaccine-induced CD8+ T-cell responses to MAGE-3 correlate with clinical outcome in patients with melanoma.
PubMed·2003· 43 cited
Identification of HLA-A*03, A*11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis
Journal of Immunological Methods·2000· 27 cited
HLA-Independent Heterogeneity of CD8+ T Cell Responses to MAGE-3, Melan-A/MART-1, gp100, Tyrosinase, MC1R, and TRP-2 in Vaccine-Treated Melanoma Patients
The Journal of Immunology·1998· 87 citedOpen Access
The Cortical Neuron
Science·1996
Computer simulations of morphologically reconstructed CA3 hippocampal neurons
Journal of Neurophysiology·1995· 172 cited
Multiple components of calcium current in acutely dissociated dentate gyrus granule neurons
Journal of Neurophysiology·1994· 59 cited
Identification of Melanoma Cell Surface Antigens Immunogenic in Mice
Cancer Biotherapy·1994· 3 cited
Induction of B16 melanoma melanogenesis by a serum-free synthetic medium
Experimental Cell Research·1992· 16 cited
Effect of Cell Wall Skeleton and Monophosphoryl Lipid A Adjuvant on the Immunogenicity of a Murine B16 Melanoma Vaccine
JNCI Journal of the National Cancer Institute·1991· 17 citedOpen Access
Immunogenicity and tumor protective activity of B16 melanoma vaccines.
PubMed·1989· 2 cited
Glutamate and dynorphin release from a subcellular fraction enriched in hippocampal mossy fiber synaptosomes
Brain Research Bulletin·1988· 92 cited
4-Aminopyridine produces epileptiform activity in hippocampus and enhances synaptic excitation and inhibition
Journal of Neurophysiology·1987· 277 cited
page 1 of 2Next →

Frequent Co-authors

Jean‐Claude Bystryn(10), Sandra R. Reynolds(5), George Melnykovych(5), Richard L. Shapiro(3), Jean‐Claude Bystryn(3), Daniel B. Drachman(3), Richard Hudson(3), Warren J. Strittmatter(2), Alessandro Sette(2), Ruth Oratz(2), M Fotino(2), Daniel F. Roses(2), Webster K. Cavenee(2), J C Bystryn(2), Paul Rutecki(1), Frank J. Lebeda(1), Michele Migliore(1), Erik P. Cook(1), David B. Jaffe(1), Dennis A. Turner(1)